![DLBCL](https://www.adcreviews.com/wp-content/uploads/2022/08/DLBCL-300x140.jpg)
FDA accepts Polivy in combination with R-CHP for DLBCL
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma The Food and Drug Administration (FDA)
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma The Food and Drug Administration (FDA)